Literature DB >> 22146435

Class of once-weekly diabetes drugs poised for approval.

Hannah Waters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22146435     DOI： 10.1038/nm1211-1528b

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.

Authors:  Michaela Diamant; Luc Van Gaal; Stephen Stranks; Justin Northrup; Dachuang Cao; Kristin Taylor; Michael Trautmann
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.